Consort Medical PLC Director/PDMR Shareholding (2564C)
07 2월 2020 - 1:31AM
UK Regulatory
TIDMCSRT
RNS Number : 2564C
Consort Medical PLC
06 February 2020
Consort Medical plc ("Consort" or the "Company")
Notification and public disclosure by persons discharging
managerial responsibilities ("PDMRs")
6 February 2020
Acquisition of entire issued and to be issued share capital of
the Company by Recipharm Holdings Limited ("Recipharm"), a
wholly-owned direct subsidiary of Recipharm AB, by way of a
recommended cash offer (the "Offer") - exercise of share options
held by PDMRs and disposal by PDMRs of shares under the Offer
Consort announces the following in relation to the PDMRs listed
in the table below:
-- on 4 February 2020 (the "Takeover Date"), the PDMRs exercised
share options (the "Options") under the Company's Share Plans (as
detailed further in the table and the notifications below) which
became exercisable in connection with the Offer, and the PDMRs
became entitled to ordinary shares ("Shares") in the Company;
and
-- on 5 February 2020, the PDMRs disposed of the Shares
resulting from such exercise, and their SIP Shares (where relevant)
(as detailed further in the table and the notifications below), to
Recipharm under the terms of the Offer.
The Options were granted to the PDMRs under the Consort
Performance Share Plan (the "PSP"), the Consort Deferred Bonus Plan
(the "DBP") and the Consort Sharesave Plan (the "Sharesave Plan").
Certain of the PDMRs also hold Shares under the Consort Share
Incentive Plan (the "SIP").
The Options were exercised by the PDMRs conditionally on the
Takeover Date, and the PDMRs accepted the Offer in respect of the
resulting Shares, under the terms of Recipharm's proposal made in
accordance with Rule 15 of the Takeover Code. The PDMRs instructed
the SIP Trustee to accept the Offer in respect of their SIP Shares,
in accordance with the trust deed and rules of the SIP.
As set out in the document containing the Offer, the effect of
the Offer on the interests the PDMRs does not differ from its
effect on the interests of any other option holder or
shareholder.
The exercise of the Options was satisfied by using all the
Shares held in the Consort Medical plc Employee Share Ownership
Trust, with the balance of Options satisfied by the issue of new
Shares.
Following the acquisition by Recipharm of the Shares as detailed
in this announcement, the PDMRs listed below hold no Shares in the
Company.
Director/PDMR DBP Shares PSP Shares Sharesave SIP Shares Total Shares Total Shares
Shares exercised retained
and sold
to Recipharm
Jonathan
Glenn 50,875 160,599 193 9,065 220,732 0
----------- ----------- ---------- ----------- -------------- -------------
Paul Hayes 19,120 127,108 387 467 147,082 0
----------- ----------- ---------- ----------- -------------- -------------
Keyvan Djamarani 16,522 59,688 387 1,971 78,568 0
----------- ----------- ---------- ----------- -------------- -------------
Enquiries: Andrew Jackson Company Secretary 01442 867920
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Jonathan Glenn
--------------------------------- ------------------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------
a) Position/status CEO
--------------------------------- ------------------------------------------------------
b) Initial notification Initial
/Amendment
--------------------------------- ------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------------
a) Name Consort Medical plc
--------------------------------- ------------------------------------------------------
b) LEI 2138001TBP74FD66QT38
--------------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------------------
a) Description of the Ordinary 10p shares
financial instrument,
type of instrument
Identification code ISIN: GB0000946276
b) Nature of the transaction 1. Exercise of Options under the
Deferred Bonus Plan and the Performance
Share Plan
2. Sale of Shares resulting from
exercise under the terms of the Offer
3. Exercise of Options under the
Company's Sharesave Scheme
4. Sale of the Sharesave shares resulting
from the exercise under the terms
of the offer
5. Sale of the Share Incentive Plan
shares under the terms of the offer
--------------------------------- ------------------------------------------------------
c) Price(s) and volume(s)
-------------------------------- -----------------
Price(s) Volume(s)
-------------------------------- -----------------
1. GBP0.00 211,474
----------------------------------------------------------------------- -----------------
2. GBP10.10 211,474
----------------------------------------------------------------------- -----------------
3. GBP7.74 193
----------------------------------------------------------------------- -----------------
4. GBP10.10 193
----------------------------------------------------------------------- -----------------
5. GBP10.10 9,065
----------------------------------------------------------------------- -----------------
d) Aggregated information
n/a
- Aggregated volume
- Price
e) Date of the transaction Exercise of options: 4 February 2020
Sale of shares under offer: 5 February
2020
--------------------------------- ------------------------------------------------------
f) Place of the transaction Exercise of options: Off market
Sale of share under offer: London
Stock Exchange
--------------------------------- ------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Paul Hayes
------------------------------ ------------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------
a) Position/status CFO
------------------------------ ------------------------------------------------------
b) Initial notification Initial
/Amendment
------------------------------ ------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------
a) Name Consort Medical plc
------------------------------ ------------------------------------------------------
b) LEI 2138001TBP74FD66QT38
------------------------------ ------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------------
a) Description of the Ordinary 10p shares
financial instrument,
type of instrument
Identification code ISIN: GB0000946276
b) Nature of the transaction 1. Exercise of Options under the
Deferred Bonus Plan and the Performance
Share Plan
2. Sale of Shares resulting from
exercise under the terms of the Offer
3. Exercise of Options under the
Company's Sharesave Scheme
4. Sale of the Sharesave shares resulting
from the exercise under the terms
of the offer
5. Sale of the Share Incentive Plan
shares under the terms of the offer
------------------------------ ------------------------------------------------------
c) Price(s) and volume(s)
----------------------------------- --------------
Price(s) Volume(s)
----------------------------------- --------------
1. GBP0.00 146,228
----------------------------------------------------------------------- --------------
2. GBP10.10 146,228
----------------------------------------------------------------------- --------------
3. GBP7.74 387
----------------------------------------------------------------------- --------------
4. GBP10.10 387
----------------------------------------------------------------------- --------------
5. GBP10.10 467
----------------------------------------------------------------------- --------------
d) Aggregated information
n/a
- Aggregated volume
- Price
e) Date of the transaction Exercise of options: 4 February 2020
Sale of shares under offer: 5 February
2020
------------------------------ ------------------------------------------------------
f) Place of the transaction Exercise of options: Off market
Sale of share under offer: London
Stock Exchange
------------------------------ ------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Keyvan Djamarani
------------------------------ ------------------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------
a) Position/status Business President Bespak
------------------------------ ------------------------------------------------------------
b) Initial notification Initial
/Amendment
------------------------------ ------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------------
a) Name Consort Medical plc
------------------------------ ------------------------------------------------------------
b) LEI 2138001TBP74FD66QT38
------------------------------ ------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------------------
a) Description of the Ordinary 10p shares
financial instrument,
type of instrument
Identification code ISIN: GB0000946276
b) Nature of the transaction 1. Exercise of Options under the
Deferred Bonus Plan and the Performance
Share Plan
2. Sale of Shares resulting from
exercise under the terms of the Offer
3. Exercise of Options under the
Company's Sharesave Scheme
4. Sale of the Sharesave shares resulting
from the exercise under the terms
of the offer
5. Sale of the Share Incentive Plan
shares under the terms of the offer
------------------------------ ------------------------------------------------------------
c) Price(s) and volume(s)
--------------------------------------- ----------------
Price(s) Volume(s)
--------------------------------------- ----------------
1. GBP0.00 76,210
--------------------------------------------------------------------------- ----------------
2. GBP10.10 76,210
--------------------------------------------------------------------------- ----------------
3. GBP7.74 387
--------------------------------------------------------------------------- ----------------
4. GBP10.10 387
--------------------------------------------------------------------------- ----------------
5. GBP10.10 1,971
--------------------------------------------------------------------------- ----------------
d) Aggregated information
n/a
- Aggregated volume
- Price
e) Date of the transaction Exercise of options: 4 February 2020
Sale of shares under offer: 5 February
2020
------------------------------ ------------------------------------------------------------
f) Place of the transaction Exercise of options: Off market
Sale of share under offer: London
Stock Exchange
------------------------------ ------------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHQQLFBBLLLBBV
(END) Dow Jones Newswires
February 06, 2020 11:31 ET (16:31 GMT)
Consort Medical (LSE:CSRT)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Consort Medical (LSE:CSRT)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
